Effects of Isotretinoin on the Growth Rate and Thickness of the Nail Plate

December 3, 2020 updated by: Sinan Özçelik

Effects of Isotretinoin on the Morphology, Growth Rate, and Thickness of the Nail Plate

The nail is an important skin appendage which can provide information about the person's overall health status in addition to having several important functions such as protection, tactile sensation, grasping. Many nail abnormalities which can have considerable psychological impact are side effects of drug administration. Retinoids have various effects on nails. Although isotretinoin as a retinoid has been associated with both decreased and increased nail growth, the great majority of such associations are not evidence-based. So, it was aimed to investigate the effects of isotretinoin on morphology, growth rate, and thickness of the nail plate.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Isotretinoin has various side effects that affect many organ systems. Some side effects such as nail changes, which do not require treatment cessation, can limit the use of isotretinoin by impairing the patient's quality of life. Although it is known that isotretinoin has various effects on the nails, there is very limited data on effects of isotretinoin on the nails. Therefore, it was aimed to investigate the effect of isotretinoin on the morphology, growth rate, and thickness of the nail plate. The patients aged 18-45 that were planned to begin treatment with isotretinoin for acne in the outpatient clinic and a control group consisting of healthy volunteers are planned to be included in the study. A dermatological examination of skin and nails is conducted in all participants. Isotretinoin treatment at 0.5 mg/kg per day in 2 divided doses will be started to patients with acne. The length and thickness of nail plate are measured by digital caliper before isotretinoin treatment, and repeated during the control visits of the participants at 30 day intervals for 6 months. All the examination and measurements are carried out in both groups.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Balıkesir, Turkey, 10145
        • Balikesir University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All participants who are admitted to the outpatient clinic of our tertiary referral hospital were planned to include in the study.

Description

Inclusion Criteria:

  • The patients that were planned to begin treatment with isotretinoin for acne

Exclusion Criteria:

  • Having known diseases (dermatological or systemic disorders) affecting the growth rate and thickness of nail plate
  • Using systemic or topical drugs with known effects on nail
  • Having traumatic nail abnormalities (onychotillomania, nail biting, habit-tic deformity)
  • Having no visible lunula
  • Describing any trauma (including cutting or filing nails) between the two measurements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
isotretinoin
The patients aged 18-45 that were planned to begin treatment with isotretinoin for acne
The effects of isotretinoin on morphology, growth rate, and thickness of the nail plate
Other Names:
  • Roaccutane
  • Zoretanin
  • D10BA01
control
Healthy volunteers aged 18-45 without any diseases/drugs affecting the nail

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The lengths and thicknesses of nail plate according to months in the isotretinoin group
Time Frame: 30 days
These are the measures of monthly nail growth rates and thicknesses of nail plate. The lengths and thicknesses of nail plate are recorded in millimeters. Results are presented as mean or median according to whether they are normally distributed or not.
30 days
The lengths and thicknesses of nail plate according to months in the control group
Time Frame: 30 days
These are the measures of monthly nail growth rates and thicknesses of nail plate. The lengths and thicknesses of nail plate are recorded in millimeters. Results are presented as mean or median according to whether they are normally distributed or not.
30 days
Comparison of nail growth rate according to groups
Time Frame: 30 days
This is the comparison of monthly nail growth rates according to groups. The values of nail growth rates are recorded in millimeters per month.
30 days
Comparison of nail thickness according to groups
Time Frame: 30 days
This is the comparison of monthly nail thickness according to groups. The values of nail thickness are recorded in millimeters.
30 days
The effect of group on the change in growth rate of nail plate by time
Time Frame: 30 days
It is investigated using repeated measures analysis of variance
30 days
The effect of group on the change in thickness of nail plate by time
Time Frame: 30 days
It is investigated using repeated measures analysis of variance
30 days
Changes in nail growth rates by time in the isotretinoin group
Time Frame: 30 days
It is investigated using repeated measures analysis of variance
30 days
Changes in nail thickness by time in the isotretinoin group
Time Frame: 30 days
It is investigated using repeated measures analysis of variance
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Sinan Özçelik, MD, Balıkesir Üniversitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 22, 2019

Primary Completion (Actual)

September 1, 2020

Study Completion (Actual)

October 1, 2020

Study Registration Dates

First Submitted

November 28, 2020

First Submitted That Met QC Criteria

December 3, 2020

First Posted (Actual)

December 9, 2020

Study Record Updates

Last Update Posted (Actual)

December 9, 2020

Last Update Submitted That Met QC Criteria

December 3, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

It is not yet known if there will be a plan to make IPD available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nail Abnormality

Clinical Trials on Isotretinoin

3
Subscribe